Arcturus Therapeutics Holdings Inc

ARCT

Healthcare|Biotechnology|USA

$6.97

-0.19 (-2.65%)

Tangible Book

$6.73

Upcoming Data Readouts (1)

Jun 2027

Est. completion

P2Cystic Fibrosis

Safety, Tolerability and Efficacy Study of ARCT-032 in People With Cystic Fibrosis